Join Mailing List   |   Jobs   |   Print Page   |   Contact Us   |   Sign In   |   Join
ISTH Mexico Workshop Program
Share |

Organized in Partnership with Grupo CLAHT and Sociedad Mexicana de Trombosi y Hemostasia (SOMETH)

Workshop Home | Registration


Target Audience:

  • early career professionals
  • trainees in hemostasis, hematology, transfusion medicine, vascular medicine, or intensive care medicine,
  • a Ph.D. wishing to acquire clinical and basic knowledge in the field, or
  • a senior hematologist looking for an update.


  1. Obtain an understanding of the latest developments in VTE and thrombosis management

  2. Learn to identify, diagnose and have knowledge of the latest treatment for patients with risk of thrombosis

  3. Have the opportunity to network with leading experts in the field of thrombosis and hemostasis, benefiting from the small training size (200 maximum participants)

 Language: Spanish to English and English to Spanish translation will be available.


Detailed Program

Day 1: May 31

Time Event Speaker
12:00-14:00 Attendee Arrival and Registration
14:00-15:00 Lunch
SESSION: Lunch Symposium
15:00-15:20 Course Introduction / Introducción al Curso
Global Impact of Thrombosis / Impacto Global de la Trombosis
- Highlights of the Course / Puntos Principals del Curso
- Blueprint of Course / Plan General del Curso
Claire McLintock
15:20-15:50 Preserving the Body’s Vital Flow
Overview of Hemostasis and Thrombosis / Revisión de Hemostasia y Trombosis
- Coagulation Cascade - Procoagulants, Natural Anticoagulants
- TFPI, TAFI, Platelets, VWF
Jeffrey Weitz
15:50-16:15 Aquired Risk Factors for VTE: Predictive scores and D-Dimmers
Aquired risk factor for VTE Escalas: predictivas y Dímeros -D
16:15-16:30 Q&A
16:30-17:10 Keynote Speaker
The Emerging Role of NETs in Venous Thrombosis and Immunothrombosis
El Papel de NETs en TEV y en Inmunotrombosis
Jose Antonio Diaz
17:10-17:40 Break
17:40-18:40 Case Presentations (Specific to Session 1 topics)
Presentacion de Casos (Temas de la session I)
(10 minute per case, 10 minute discussion. Two prepared cases and one from the audience)
TBC (prepared case on risk factors of thrombosis)
TBC (prepared case on bleeding)
Jeffrey Weitz (moderating a participant-presented case)
SESSION: Special Populations
18:40-19:05 Pregnancy / Embarazo: Venous Thromboembolism in Pregnancy Claire McLintock
19:05-19:30 Thrombosis in Unusual Sites / Trombosis en Sitios Inusuales:
CNS Venous Thrombosis / Trombosis Venosa Intracraneana
Retinal Thrombosis / Trombosis Retiniana
Fernando Barinagarrementería Aldatz
19:30-19:55 Pediatric Pulmonary Embolism Cases / Pediatría Embolismo Pulmonar TBC
19:55-20:20 Cancer and Thrombosis / Cáncer y Trombosis:
How to Personalize Treatment / Como Personalizar el Tratamiento.
20:20-20:30 Q&A
20:30 Welcome Dinner / Cena de Bienvenida

Day 2: June 1

Time Event Speaker
SESSION: Arterial thrombosis / Trombosis Arterial
8:30-8:55 Pathophysiology of Stroke: State of the Art / Patofisiología de EVC TBC
8:55-9:20 Acute Stroke Treatment: Including Lytic Therapy
Tratamiento de EVC Agudo: Incluyendo Terapia Lítica
Fernando Barinagarrementería Aldatz
9:20-9:45 Peripheral Arterial Occlusion: Treatment
Thrombosis Arterial Periférica: Tratamiento
(Including how to Anticoagulate Vascular Grafts & Vascular Anastomosis / Anticoagulación en Injertos y Anastomosis Vasculares)
Ignacio Escotto-Sanchez
9:45-10:00 Q&A
10:00 -10:30 Break
SESSION: Special Interactive Topics on Arterial Thrombosis / Temas Interactivos sobre Trombosis Arterial
10:30-10:55 Arterial Thrombosis and Valvular Disease in APS: Management / Trombosis Arterial y Enfermedad Valcular en SAF: Tratamiento TBC
10:55-11:20 Mechanical Heart Valves/Peri-op Management / Manejo Peri-operatorio de Válvulas Mecánicas Raúl Izaguirre Ávila
11:20-11:45 A.Fib as a cause of Arterial Thrombosis: Emphasis on Prevention / Fibrilación Auricular como causa de Trombosis Arterial: Enfasis en Prevención Manlio Marquez Murillo
11:45-12:00 Q&A
SESSION: Introduction to Antithrombotics / Introducción a Antitrombóticos
12:00-12:25 Antiplatelets Overview and Peri-op Management / Introducción a Antiplaquetarios y Manejo Perioperatorio Carlos Areán Martínez
12:25-12:50 Primary and Secondary CAD Prevention / Prevención Primaria y Secundaria de ECA Armando García Castillo
12:50-13:15 Overview of Anticoagulants in use: Clinical and Lab Approach / Anticoagulantes en uso: Punto de Vista Clínico y de Laboratorio. Scott Kaatz
13:15-13:30 Q&A
13:30-14:30 Lunch
14:30-15:00 How to Manage Pediatric VTE / Tratamiento de TEV en Pediatría. TBC
SESSION: VTE / Tromboembolia Venosa
15:00-15:25 Prophylaxis for VTE in the clinical Patient / Profilaxis para TEV en pacientes hospitalizados. Suely Rezende
15:25-15:50 VTE Diagnosis – Imaging / Dx TEV – en Imágenes TBC
15:50-16:00 Q&A
16:00-17:00 Clinical Cases with Images and Audience Response / Casos Clínicos con Imagines y Respuesta de la Audiencia
(3 cases, 20 minutes each)
TBC (VTE case – ideally rare or difficult diagnosis)
Claire McLintock (pregnancy/women’s case)
TBC (pediatric case)
18:00-19:00 Meet the Expert / Reunión con un Experto (separate small interactive 1 hr sessions - sign-up 20 personas max.)
Difficult Cases in Treatment of Thrombosis in Patients / Casos dificílies en el Tratamiento de Trombosis. Evelyn Cortina de la Rosa & TBC
Management of Catastrophic APS / Tratamiento de SAF Catastrófico Mary Carmen Amigo Castañeda & TBC
Case Discussions in Pediatric Thrombosis / Discusión de Casos en Trombosis en Pediatría TBC
Pathophysiology and Treatment of DIC and Inmunothrombosis (Fisiopatología y tratamiento de CID e Inmunotrombosis) Jose Antonio Díaz &TBC

Day 3: June 2

Time Event Speaker
SESSION: Complications of  VTE and Treatment / Complicaciones de Tratamiento de TEV
8:30-8:55 Acute Thrombolysis: Risks & Benefits in High Risk Pulmonary Embolism / Beneficios y Riesgos de la Trombolisis en TEP de Alto Riesgo Carlos Jerjes Sanchez-Díaz
8:55-9:20 Pathogenesis, Prevention  and Management of Post-Thrombotic Syndrome / Patogenia, Prevención y Tratamiento del Síndrome Post-Trombótico Jose Antonio Diaz
9:20-9:45 Case Discussion: Pathogenesis, Diagnosis and Treatment of Chronic Thromboembolic Pulmonary Hypertension / Discusión de Casos: Patogenia, Diagnóstico y Tratamiento de Hipertensión Pulmonar Tromboembólica Carlos Jerjes Sanchez-Díaz
9.45-10:30 Plenary Session:
Ongoing Studies and Emerging Antithrombotic Treatment Agents / Nuevos Tratamientos Antitrombóticos (35 min + 10 for questions)
Jeffrey Weitz
10:30-11:00 Break
SESSION: Problem-based Laboratory Approach / Enfoque en el Laboratorio Basado en Problemas
11:00-11:20 The lab in the diagnosis of APS/ El laboratorio en el diagnostic de Síndrome Antifosfolípido. TBC
11:20-11:40 Prothrombotic Molecular Changes in VWF in A.Fib and CVA / Alteraciones Moleculares Protrombóticas del FVW en FA y EVC Marta Eva Viveros
11:40-12:00 Thrombotic Throbocytopenic Purpura and Hemolytic Uremic Syndrome  / PTT y SUH: 
Clinical and Laboratory diagnosis / Diagnóstico Clínico y de Laboratorio
12:00-12:20 Hereditary Thrombophilia / Trombofilia Hereditaria
Does HT Guide Management / Impacto en el Tratamiento de TEV?
12:20-12:40 Some simple cues to order hereditary thrombophilia studies, when indicated / Algunas claves simples para solicitar estudios de TH, cuando está justificado TBC
12:40-12:50 Q&A
SESSION: Interactive Case Presentations & Audience Response
Management of Bleeding Complications on Anticoagulants / Tratamiento de Complicaciones Hemorrágicas
12:50-13:10 DOACS Scott Kaatz
13:10-13:30 VKAs and Heparin Suely Rezende
13:30-13:45 Q&A
13:45-14:15 Stump the Expert: Case discussions / Discusión de Casos Ignacio Escotto-Sanchez (Vascular surgery)
TBC (Pediatrics)
Scott Kaatz (Adult hematology)
14:15: 14:30 Evaluation and End of Meeting / Evaluación y Final de la Reunión



Membership Management Software Powered by YourMembership  ::  Legal